No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr7:112061000-112089800 |
Weak transcription |
Aorta |
Aorta
|
2 |
chr7:112064200-112088400 |
Weak transcription |
Psoas Muscle |
Psoas
|
3 |
chr7:112064400-112074800 |
Weak transcription |
A549 |
lung
|
4 |
chr7:112065800-112079800 |
Weak transcription |
Pancreas |
Pancrea
|
5 |
chr7:112068600-112077200 |
Weak transcription |
H1 BMP4 Derived Mesendoderm Cultured Cells |
ES cell derived
|
6 |
chr7:112071000-112077000 |
Weak transcription |
Breast Myoepithelial Primary Cells |
Breast
|
7 |
chr7:112072000-112073800 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
8 |
chr7:112072400-112073800 |
Enhancers |
Primary neutrophils fromperipheralblood |
blood
|
9 |
chr7:112072400-112074600 |
Enhancers |
Dnd41 |
blood
|
10 |
chr7:112072400-112074800 |
Weak transcription |
Muscle Satellite Cultured Cells |
--
|
11 |
chr7:112073000-112073800 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
12 |
chr7:112073200-112073800 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
13 |
chr7:112073200-112073800 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
14 |
chr7:112073200-112074200 |
Enhancers |
Placenta Amnion |
Placenta Amnion
|
15 |
chr7:112073400-112073800 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
16 |
chr7:112073400-112073800 |
Enhancers |
K562 |
blood
|
17 |
chr7:112073600-112073800 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
18 |
chr7:112073600-112073800 |
Enhancers |
HSMMtube |
muscle
|
19 |
chr7:112073600-112074800 |
Weak transcription |
NHEK |
skin
|
20 |
chr7:112073600-112075000 |
Weak transcription |
HMEC |
breast
|
21 |
chr7:112073600-112075200 |
Weak transcription |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|